Macrophage Activation Syndrome.
Nigrovic PA.
Arthritis Rheumatol. 2025 Apr;77(4):367-379. doi: 10.1002/art.43052. Epub 2024 Dec 12.
Macrophage Activation Syndrome.
Ravelli A, Davì S, Minoia F, Martini A, Cron RQ.
Hematol Oncol Clin North Am. 2015 Oct;29(5):927-41. doi: 10.1016/j.hoc.2015.06.010. Epub 2015 Aug 25.
Heterogeneity of macrophage activation syndrome and treatment progression.
Dong Y, Wang T, Wu H.
Front Immunol. 2024 Apr 26;15:1389710. doi: 10.3389/fimmu.2024.1389710. eCollection 2024.
Intravenous anakinra for the treatment of haemophagocytic lymphohistiocytosis/macrophage activation syndrome: A systematic review.
Charlesworth JEG, Kavirayani A.
Eur J Haematol. 2023 Sep;111(3):458-476. doi: 10.1111/ejh.14029. Epub 2023 Jun 21.
Macrophage Activation Syndrome in Viral Sepsis.
Papageorgiou D, Gogos C, Akinosoglou K.
Viruses. 2024 Jun 22;16(7):1004. doi: 10.3390/v16071004.
Macrophage Activation Syndrome in the Setting of Rheumatic Diseases.
Chatham WW.
Adv Exp Med Biol. 2024;1448:399-408. doi: 10.1007/978-3-031-59815-9_27.
Macrophage Activation Syndrome.
Sen ES, Clarke SL, Ramanan AV.
Indian J Pediatr. 2016 Mar;83(3):248-53. doi: 10.1007/s12098-015-1877-1. Epub 2015 Sep 24.
Macrophage Activation Syndrome: Not Just for Rheumatologists Anymore.
Iosim S, Henderson LA.
Hematol Oncol Clin North Am. 2025 Jun;39(3):597-615. doi: 10.1016/j.hoc.2025.02.004. Epub 2025 Mar 24.
Pathogenesis of Hemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome: A Case Report and Review of the Literature.
Gioia C, Paroli M, Izzo R, Di Sanzo L, Rossi E, Pignatelli P, Accapezzato D.
Int J Mol Sci. 2024 May 29;25(11):5921. doi: 10.3390/ijms25115921.
Macrophage activation syndrome in Sepsis: from pathogenesis to clinical management.
Chen S, Zhang C, Luo J, Lin Z, Chang T, Dong L, Chen D, Tang ZH.
Inflamm Res. 2024 Dec;73(12):2179-2197. doi: 10.1007/s00011-024-01957-7. Epub 2024 Oct 15.
